Published in Proc Natl Acad Sci U S A on March 25, 2005
Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis. Lancet (2008) 9.05
Malaria: progress, perils, and prospects for eradication. J Clin Invest (2008) 6.54
Measuring malaria endemicity from intense to interrupted transmission. Lancet Infect Dis (2008) 6.53
Factors determining the occurrence of submicroscopic malaria infections and their relevance for control. Nat Commun (2012) 5.34
The impact of response to the results of diagnostic tests for malaria: cost-benefit analysis. BMJ (2008) 4.02
Stable and unstable malaria hotspots in longitudinal cohort studies in Kenya. PLoS Med (2010) 3.78
Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria. Infect Immun (2008) 3.51
Dried blood spots as a source of anti-malarial antibodies for epidemiological studies. Malar J (2008) 3.02
Rapid assessment of malaria transmission using age-specific sero-conversion rates. PLoS One (2009) 2.94
The multiplicity of malaria transmission: a review of entomological inoculation rate measurements and methods across sub-Saharan Africa. Malar J (2009) 2.66
Serologic markers for detecting malaria in areas of low endemicity, Somalia, 2008. Emerg Infect Dis (2010) 2.59
Using serological measures to monitor changes in malaria transmission in Vanuatu. Malar J (2010) 2.47
Continued decline of malaria in The Gambia with implications for elimination. PLoS One (2010) 2.47
Spatial prediction of Plasmodium falciparum prevalence in Somalia. Malar J (2008) 2.44
Long-lived antibody and B Cell memory responses to the human malaria parasites, Plasmodium falciparum and Plasmodium vivax. PLoS Pathog (2010) 2.30
Age patterns of severe paediatric malaria and their relationship to Plasmodium falciparum transmission intensity. Malar J (2009) 2.19
Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specific. Infect Immun (2008) 2.18
Serological markers suggest heterogeneity of effectiveness of malaria control interventions on Bioko Island, equatorial Guinea. PLoS One (2011) 2.18
The contribution of Plasmodium chabaudi to our understanding of malaria. Trends Parasitol (2011) 1.99
Malaria rapid diagnostic tests in elimination settings--can they find the last parasite? Clin Microbiol Infect (2011) 1.98
Reconstructing historical changes in the force of infection of dengue fever in Singapore: implications for surveillance and control. Bull World Health Organ (2008) 1.91
Determination of the processes driving the acquisition of immunity to malaria using a mathematical transmission model. PLoS Comput Biol (2007) 1.87
Timing of intermittent preventive treatment for malaria during pregnancy and the implications of current policy on early uptake in north-east Tanzania. Malar J (2008) 1.85
Surveillance for malaria elimination in Swaziland: a national cross-sectional study using pooled PCR and serology. PLoS One (2012) 1.81
Dynamics of polymorphism in a malaria vaccine antigen at a vaccine-testing site in Mali. PLoS Med (2007) 1.78
A quantitative analysis of transmission efficiency versus intensity for malaria. Nat Commun (2010) 1.66
Comparison of surveillance methods applied to a situation of low malaria prevalence at rural sites in The Gambia and Guinea Bissau. Malar J (2009) 1.63
Association of sub-microscopic malaria parasite carriage with transmission intensity in north-eastern Tanzania. Malar J (2011) 1.63
Overuse of artemisinin-combination therapy in Mto wa Mbu (river of mosquitoes), an area misinterpreted as high endemic for malaria. Malar J (2008) 1.51
Malaria diagnostic testing and treatment practices in three different Plasmodium falciparum transmission settings in Tanzania: before and after a government policy change. Malar J (2011) 1.50
Measuring changes in Plasmodium falciparum transmission: precision, accuracy and costs of metrics. Adv Parasitol (2014) 1.44
Population, behavioural and environmental drivers of malaria prevalence in the Democratic Republic of Congo. Malar J (2011) 1.40
A Seroepidemiological Study of Serogroup A Meningococcal Infection in the African Meningitis Belt. PLoS One (2016) 1.39
Age-adjusted Plasmodium falciparum antibody levels in school-aged children are a stable marker of microgeographical variations in exposure to Plasmodium infection. BMC Infect Dis (2007) 1.37
Epidemiology of malaria in an area prepared for clinical trials in Korogwe, north-eastern Tanzania. Malar J (2009) 1.34
Survey for asymptomatic malaria cases in low transmission settings of Iran under elimination programme. Malar J (2012) 1.32
Targets of antibodies against Plasmodium falciparum-infected erythrocytes in malaria immunity. J Clin Invest (2012) 1.31
The use of schools for malaria surveillance and programme evaluation in Africa. Malar J (2009) 1.31
Continuing intense malaria transmission in northern Uganda. Am J Trop Med Hyg (2011) 1.30
Low density parasitaemia, red blood cell polymorphisms and Plasmodium falciparum specific immune responses in a low endemic area in northern Tanzania. BMC Infect Dis (2009) 1.29
School-based surveys of malaria in Oromia Regional State, Ethiopia: a rapid survey method for malaria in low transmission settings. Malar J (2011) 1.29
Interaction of malaria with a common form of severe thalassemia in an Asian population. Proc Natl Acad Sci U S A (2009) 1.29
Effect of the pre-erythrocytic candidate malaria vaccine RTS,S/AS01E on blood stage immunity in young children. J Infect Dis (2011) 1.28
Sero-epidemiological evaluation of changes in Plasmodium falciparum and Plasmodium vivax transmission patterns over the rainy season in Cambodia. Malar J (2012) 1.27
Fighting malaria in Madhya Pradesh (Central India): are we losing the battle? Malar J (2009) 1.27
Parasite prevalence: a static measure of dynamic infections. Am J Trop Med Hyg (2007) 1.27
Spatio-temporal malaria transmission patterns in Navrongo demographic surveillance site, northern Ghana. Malar J (2013) 1.27
On the road to eliminate malaria in Sri Lanka: lessons from history, challenges, gaps in knowledge and research needs. Malar J (2014) 1.24
Estimating individual exposure to malaria using local prevalence of malaria infection in the field. PLoS One (2012) 1.24
Humoral response to the Anopheles gambiae salivary protein gSG6: a serological indicator of exposure to Afrotropical malaria vectors. PLoS One (2011) 1.24
Serology for trachoma surveillance after cessation of mass drug administration. PLoS Negl Trop Dis (2015) 1.21
Measurement of Plasmodium falciparum transmission intensity using serological cohort data from Indonesian schoolchildren. Malar J (2013) 1.20
Reduced prevalence of malaria infection in children living in houses with window screening or closed eaves on Bioko Island, equatorial Guinea. PLoS One (2013) 1.19
Malaria risk factors in North West Tanzania: the effect of spraying, nets and wealth. PLoS One (2013) 1.17
Low prevalence of antibodies to preerythrocytic but not blood-stage Plasmodium falciparum antigens in an area of unstable malaria transmission compared to prevalence in an area of stable malaria transmission. Infect Immun (2008) 1.17
The impact of hotspot-targeted interventions on malaria transmission: study protocol for a cluster-randomized controlled trial. Trials (2013) 1.17
Serological measures of malaria transmission in Haiti: comparison of longitudinal and cross-sectional methods. PLoS One (2014) 1.14
The breadth, but not the magnitude, of circulating memory B cell responses to P. falciparum increases with age/exposure in an area of low transmission. PLoS One (2011) 1.14
Serological markers for monitoring historical changes in malaria transmission intensity in a highly endemic region of Western Kenya, 1994-2009. Malar J (2014) 1.14
Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities. Proc Natl Acad Sci U S A (2015) 1.13
Antibody responses of domestic animals to salivary antigens of Triatomainfestans as biomarkers for low-level infestation of triatomines. Int J Parasitol (2009) 1.12
Establishing the extent of malaria transmission and challenges facing pre-elimination in the Republic of Djibouti. BMC Infect Dis (2011) 1.11
A multiplex assay for the simultaneous detection of antibodies against 15 Plasmodium falciparum and Anopheles gambiae saliva antigens. Malar J (2010) 1.11
Hot spot or not: a comparison of spatial statistical methods to predict prospective malaria infections. Malar J (2014) 1.09
Age-specific malaria seroprevalence rates: a cross-sectional analysis of malaria transmission in the Ouest and Sud-Est departments of Haiti. Malar J (2014) 1.09
Combined DNA extraction and antibody elution from filter papers for the assessment of malaria transmission intensity in epidemiological studies. Malar J (2013) 1.07
Seroepidemiological and parasitological evaluation of the heterogeneity of malaria infection in the Gambia. Malar J (2013) 1.07
A comparative study of the genetic diversity of the 42kDa fragment of the merozoite surface protein 1 in Plasmodium falciparum and P. vivax. Infect Genet Evol (2006) 1.07
Marked variation in MSP-119 antibody responses to malaria in western Kenyan highlands. BMC Infect Dis (2012) 1.07
Estimation of recent and long-term malaria transmission in a population by antibody testing to multiple Plasmodium falciparum antigens. J Infect Dis (2014) 1.07
Acquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of response. Infect Immun (2014) 1.06
Simulation of malaria epidemiology and control in the highlands of Western Kenya. Malar J (2012) 1.06
IgG responses to Anopheles gambiae salivary antigen gSG6 detect variation in exposure to malaria vectors and disease risk. PLoS One (2012) 1.06
Malaria incidence and efficacy of intermittent preventive treatment in infants (IPTi). Malar J (2007) 1.06
The dynamics of naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs230 & Pfs48/45 in a low endemic area in Tanzania. PLoS One (2010) 1.06
The spatial-temporal clustering of Plasmodium falciparum infection over eleven years in Gezira State, The Sudan. Malar J (2010) 1.06
Evaluating controlled human malaria infection in Kenyan adults with varying degrees of prior exposure to Plasmodium falciparum using sporozoites administered by intramuscular injection. Front Microbiol (2014) 1.05
Human saliva as a source of anti-malarial antibodies to examine population exposure to Plasmodium falciparum. Malar J (2011) 1.03
Seasonal changes in the antibody responses against Plasmodium falciparum merozoite surface antigens in areas of differing malaria endemicity in Indonesia. Malar J (2013) 1.03
Reliability of school surveys in estimating geographic variation in malaria transmission in the western Kenyan highlands. PLoS One (2013) 1.03
Serologically defined variations in malaria endemicity in Pará state, Brazil. PLoS One (2014) 1.02
Assessing malaria transmission in a low endemicity area of north-western Peru. Malar J (2013) 1.02
Protein microarray analysis of antibody responses to Plasmodium falciparum in western Kenyan highland sites with differing transmission levels. PLoS One (2013) 1.00
Variation in exposure to Anopheles gambiae salivary gland peptide (gSG6-P1) across different malaria transmission settings in the western Kenya highlands. Malar J (2012) 0.99
Plasmodium falciparum malaria in the Peruvian Amazon, a region of low transmission, is associated with immunologic memory. Infect Immun (2012) 0.99
Immunogenic salivary proteins of Triatoma infestans: development of a recombinant antigen for the detection of low-level infestation of triatomines. PLoS Negl Trop Dis (2009) 0.99
The company malaria keeps: how co-infection with Epstein-Barr virus leads to endemic Burkitt lymphoma. Curr Opin Infect Dis (2011) 0.98
Hotspots of Malaria Transmission in the Peruvian Amazon: Rapid Assessment through a Parasitological and Serological Survey. PLoS One (2015) 0.98
A molecular epidemiological study of var gene diversity to characterize the reservoir of Plasmodium falciparum in humans in Africa. PLoS One (2011) 0.98
Immunophoretic rapid diagnostic tests as a source of immunoglobulins for estimating malaria sero-prevalence and transmission intensity. Malar J (2009) 0.98
The ears of the African elephant: unexpected high seroprevalence of Plasmodium ovale and Plasmodium malariae in healthy populations in Western Africa. Malar J (2014) 0.97
Factors associated with malaria parasitemia, anemia and serological responses in a spectrum of epidemiological settings in Uganda. PLoS One (2015) 0.96
Increased sensitivity for detecting malaria parasites in human umbilical cord blood using scaled-up DNA preparation. Malar J (2012) 0.96
Challenges and prospects for malaria elimination in the Southern Africa region. Acta Trop (2011) 0.96
Serology describes a profile of declining malaria transmission in Farafenni, The Gambia. Malar J (2015) 0.95
Epidemiological characterization of Plasmodium falciparum in the Republic of Cabo Verde: implications for potential large-scale re-emergence of malaria. Malar J (2006) 0.94
Research priorities for the development and implementation of serological tools for malaria surveillance. F1000Prime Rep (2014) 0.94
Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Lancet (1997) 13.64
A climate-based distribution model of malaria transmission in sub-Saharan Africa. Parasitol Today (1999) 12.36
Spatial and temporal heterogeneity of Anopheles mosquitoes and Plasmodium falciparum transmission along the Kenyan coast. Am J Trop Med Hyg (2003) 5.43
Specificity of the protective antibody response to apical membrane antigen 1. Infect Immun (2001) 4.51
Relationship between altitude and intensity of malaria transmission in the Usambara Mountains, Tanzania. J Med Entomol (2003) 3.98
Altitude-dependent and -independent variations in Plasmodium falciparum prevalence in northeastern Tanzania. J Infect Dis (2005) 3.75
Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1. J Infect Dis (1996) 3.49
Climate change and malaria transmission. Ann Trop Med Parasitol (1996) 3.40
Vaccination of monkeys with recombinant Plasmodium falciparum apical membrane antigen 1 confers protection against blood-stage malaria. Infect Immun (2002) 3.08
A longitudinal study of type-specific antibody responses to Plasmodium falciparum merozoite surface protein-1 in an area of unstable malaria in Sudan. J Immunol (1998) 2.94
Expression of the 19-kilodalton carboxy-terminal fragment of the Plasmodium falciparum merozoite surface protein-1 in Escherichia coli as a correctly folded protein. Mol Biochem Parasitol (1994) 2.71
Does malaria suffer from lack of memory? Immunol Rev (2004) 2.66
Estimation of incidence and recovery rates of Plasmodium falciparum parasitaemia from longitudinal data. Bull World Health Organ (1976) 2.56
Human antibody response to Plasmodium falciparum merozoite surface protein 2 is serogroup specific and predominantly of the immunoglobulin G3 subclass. Infect Immun (1995) 2.48
Fine specificity of serum antibodies to Plasmodium falciparum merozoite surface protein, PfMSP-1(19), predicts protection from malaria infection and high-density parasitemia. Infect Immun (2004) 2.31
Levels of antibodies to Plasmodium falciparum sporozoite surface antigens reflect malaria transmission rates and are persistent in the absence of reinfection. Infect Immun (1986) 2.14
Maximum likelihood for parasitologists. Parasitol Today (1994) 2.10
High prevalence of natural antibodies against Plasmodium falciparum 83-kilodalton apical membrane antigen (PF83/AMA-1) as detected by capture-enzyme-linked immunosorbent assay using full-length baculovirus recombinant PF83/AMA-1. Am J Trop Med Hyg (1994) 2.05
Incidence of Plasmodium falciparum infection in infants in relation to exposure to sporozoite-infected anophelines. Am J Trop Med Hyg (1998) 1.79
Selective recognition of malaria antigens by human serum antibodies is not genetically determined but demonstrates some features of clonal imprinting. Int Immunol (1996) 1.75
The relationship between the Plasmodium falciparum parasite ratio in childhood and climate estimates of malaria transmission in Kenya. Malar J (2004) 1.65
Lack of association between maternal antibody and protection of African infants from malaria infection. Infect Immun (2000) 1.64
Infant parasite rates and immunoglobulin M seroprevalence as a measure of exposure to Plasmodium falciparum during a randomized controlled trial of insecticide-treated bed nets on the Kenyan coast. Am J Trop Med Hyg (1996) 1.49
Genetic diversity and antigenic polymorphism in Plasmodium falciparum: extensive serological cross-reactivity between allelic variants of merozoite surface protein 2. Infect Immun (2003) 1.44
Is immunity to malaria really short-lived? Parasitol Today (1992) 1.35
Studies on the persistence of malarial antibody response. Am J Epidemiol (1968) 1.35
Circumsporozoite antibody as a serologic marker of Plasmodium falciparum transmission. Am J Trop Med Hyg (1992) 1.22
Persistence of malarial antibody. Findings in patients infected during the outbreak of malaria in Lake Vera, California, 1952-1953. Am J Trop Med Hyg (1967) 1.10
Estimating the force of malaria infection. Parasitol Today (1996) 1.04
Humoral responses against the C-terminal region of merozoite surface protein 1 can be remembered for more than 30 years in persons exposed to Plasmodium vivax. Parasitol Res (2004) 1.02
Human IgG subclass antibodies to the 19 kilodalton carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (MSP1(19)) and predominance of the MAD20 allelic type of MSP1 in Uganda. East Afr Med J (2000) 0.97
Malaria-specific memory T cells: putative roles of different types of memory responses in immunity and disease. Res Immunol (1995) 0.91
Cost-effectiveness of malaria control in sub-Saharan Africa. Lancet (1999) 5.82
The HMG domain of lymphoid enhancer factor 1 bends DNA and facilitates assembly of functional nucleoprotein structures. Cell (1992) 5.24
Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study. J Clin Oncol (2001) 4.89
Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1. J Infect Dis (1996) 3.49
The origins of a new Trypanosoma brucei rhodesiense sleeping sickness outbreak in eastern Uganda. Lancet (2001) 3.42
Predicting high-risk years for malaria in Colombia using parameters of El Niño Southern Oscillation. Trop Med Int Health (1997) 3.39
A study of general practitioners' reasons for changing their prescribing behaviour. BMJ (1996) 3.36
Structure of chicken muscle triose phosphate isomerase determined crystallographically at 2.5 angstrom resolution using amino acid sequence data. Nature (1975) 3.15
Three new members of the serine-aspartate repeat protein multigene family of Staphylococcus aureus. Microbiology (1998) 2.82
Multi-country field trials comparing wash-resistance of PermaNet and conventional insecticide-treated nets against anopheline and culicine mosquitoes. Med Vet Entomol (2005) 2.71
Absolute levels and ratios of proinflammatory and anti-inflammatory cytokine production in vitro predict clinical immunity to Plasmodium falciparum malaria. J Infect Dis (2002) 2.61
Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: immunodominant T-cell domains map to the polymorphic regions of the molecule. Proc Natl Acad Sci U S A (1988) 2.60
Fatal infection with a novel, unidentified mycobacterium in a man with the acquired immunodeficiency syndrome. N Engl J Med (1990) 2.54
Human antibody response to Plasmodium falciparum merozoite surface protein 2 is serogroup specific and predominantly of the immunoglobulin G3 subclass. Infect Immun (1995) 2.48
A burgeoning epidemic of sleeping sickness in Uganda. Lancet (2005) 2.44
IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria. Am J Trop Med Hyg (1998) 2.41
Human antibodies to the 19kDa C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 inhibit parasite growth in vitro. Parasite Immunol (1999) 2.39
Identification of human-infective trypanosomes in animal reservoir of sleeping sickness in Uganda by means of serum-resistance-associated (SRA) gene. Lancet (2001) 2.36
A nested-PCR-based schizodeme method for identifying Leishmania kinetoplast minicircle classes directly from clinical samples and its application to the study of the epidemiology of Leishmania tropica in Pakistan. J Clin Microbiol (1998) 2.35
The General Medical Council's Performance Procedures: peer review of performance in the workplace. Med Educ (2001) 2.27
Quantifying the level of under-detection of Trypanosoma brucei rhodesiense sleeping sickness cases. Trop Med Int Health (2005) 2.26
The assessment of poorly performing doctors: the development of the assessment programmes for the General Medical Council's Performance Procedures. Med Educ (2001) 2.26
Maintaining the immunological balance in parasitic infections: a role for TGF-beta? Parasitol Today (2000) 2.19
The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology. Clin Exp Immunol (2003) 2.18
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine. N Engl J Med (2015) 2.18
Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations. Clin Genet (2007) 2.15
Accrediting research practices. Br J Gen Pract (1998) 1.97
A clinical algorithm for the diagnosis of malaria: results of an evaluation in an area of low endemicity. Trop Med Int Health (2001) 1.94
The epidemiology of animal bite injuries in Uganda and projections of the burden of rabies. Trop Med Int Health (2005) 1.85
Mutations in WNT7A cause a range of limb malformations, including Fuhrmann syndrome and Al-Awadi/Raas-Rothschild/Schinzel phocomelia syndrome. Am J Hum Genet (2006) 1.85
Sleeping sickness: a tale of two diseases. Trends Parasitol (2001) 1.81
Equity and child-survival strategies. Bull World Health Organ (2008) 1.81
A family kindred with ill-used children: the burden on the community. Br J Psychiatry (1973) 1.70
Poverty in rural areas. BMJ (1998) 1.66
Twenty-four-hour ambulatory blood pressure in men and women aged 17 to 80 years: the Allied Irish Bank Study. J Hypertens (1991) 1.66
Analysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparum. Infect Immun (2000) 1.66
Permethrin-treated chaddars and top-sheets: appropriate technology for protection against malaria in Afghanistan and other complex emergencies. Trans R Soc Trop Med Hyg (2000) 1.66
Comparison of vaccination strategies for the control of dog rabies in Machakos District, Kenya. Epidemiol Infect (2002) 1.65
Transforming growth factor beta production is inversely correlated with severity of murine malaria infection. J Exp Med (1998) 1.57
Prevalence and determinants of mastitis and milk-borne zoonoses in smallholder dairy farming sector in Kibaha and Morogoro districts in Eastern Tanzania. J Vet Med B Infect Dis Vet Public Health (2004) 1.56
Forecasting disease risk for increased epidemic preparedness in public health. Adv Parasitol (2000) 1.54
High prevalence of mutations in the dihydrofolate reductase gene of Plasmodium falciparum in isolates from Tanzania without evidence of an association to clinical sulfadoxine/pyrimethamine resistance. Trop Med Int Health (1997) 1.51
An outbreak of cutaneous leishmaniasis in an Afghan refugee settlement in north-west Pakistan. Trans R Soc Trop Med Hyg (1999) 1.48
Assessing the patterns of health-seeking behaviour and awareness among sleeping-sickness patients in eastern Uganda. Ann Trop Med Parasitol (2004) 1.48
Predicting long-term survival, and the need for hormonal therapy: a meta-analysis of RTOG prostate cancer trials. Int J Radiat Oncol Biol Phys (2000) 1.47
Effect of 1997-98 El Niño on highland malaria in Tanzania. Lancet (2000) 1.43
Do radiologists still need to report chest x rays? Postgrad Med J (2009) 1.43
Simian virus 40 t antigen affects the sensitivity of cellular DNA synthesis to theophylline. J Virol (1979) 1.43
Conjugated estrogen reduces transfusion and coagulation factor requirements in orthotopic liver transplantation. Anesth Analg (1998) 1.43
Comparative efficacies of permethrin-, deltamethrin- and alpha-cypermethrin-treated nets, against Anopheles arabiensis and Culex quinquefasciatus in northern Tanzania. Ann Trop Med Parasitol (2008) 1.42
Production by activated human T cells of interleukin 4 but not interferon-gamma is associated with elevated levels of serum antibodies to activating malaria antigens. Proc Natl Acad Sci U S A (1990) 1.40
Gastric intramural pH as indicator of early allograft viability in orthotopic liver transplantation. Transplantation (1994) 1.39
Reanalyzing the 1900-1920 sleeping sickness epidemic in Uganda. Emerg Infect Dis (2004) 1.39
Radiation therapy treatment verification imaging in Australia and New Zealand. J Med Imaging Radiat Oncol (2008) 1.38
Caring for the older person: an exploration of perceptions using personal construct theory. Age Ageing (2001) 1.37
Spill-over of European bat lyssavirus type 1 into a stone marten (Martes foina) in Germany. J Vet Med B Infect Dis Vet Public Health (2004) 1.37
Appointed czars, elected presidents and windows of opportunity. Br J Psychiatry (2001) 1.32
Non-valvular atrial fibrillation (NVAF) Br J Gen Pract (1997) 1.31
Immunoglobulin M and G antibody responses to Plasmodium falciparum glutamate-rich protein: correlation with clinical immunity in Gambian children. Infect Immun (1993) 1.31
Rural general practice. Br J Gen Pract (1994) 1.30
Social gerontology in England, Scotland, and Wales: a review of recent and current research. Gerontologist (1975) 1.29
Immunization of Aotus nancymai with recombinant C terminus of Plasmodium falciparum merozoite surface protein 1 in liposomes and alum adjuvant does not induce protection against a challenge infection. Infect Immun (1996) 1.29
Interaction of malaria with a common form of severe thalassemia in an Asian population. Proc Natl Acad Sci U S A (2009) 1.29
Morbidity from malaria and immune responses to defined Plasmodium falciparum antigens in children with sickle cell trait in The Gambia. Trans R Soc Trop Med Hyg (1993) 1.28
Polymorphisms in the dihydrofolate reductase (DHFR) and dihydropteroate synthetase (DHPS) genes of Plasmodium falciparum and in vivo resistance to sulphadoxine/pyrimethamine in isolates from Tanzania. Trop Med Int Health (1998) 1.25
The General Medical Council's Performance Procedures: the development and implementation of tests of competence with examples from general practice. Med Educ (2001) 1.25
Frequent and persistent, asymptomatic Plasmodium falciparum infections in African infants, characterized by multilocus genotyping. J Infect Dis (2001) 1.24
The amino acid sequence of rabbit muscle triose phosphate isomerase. Biochem J (1975) 1.24
The cost-effectiveness of antenatal malaria prevention in sub-Saharan Africa. Am J Trop Med Hyg (2001) 1.22
Changing the first line drug for malaria treatment--cost-effectiveness analysis with highly uncertain inter-temporal trade-offs. Health Econ (2001) 1.22
The statistical analysis of data from immunoepidemiological studies. J Immunol Methods (1992) 1.22
Combined genomic and antisense analysis reveals that the transcription factor Erg is implicated in endothelial cell differentiation. Blood (2001) 1.21
T and B cell responses of Plasmodium falciparum malaria-immune individuals to synthetic peptides corresponding to sequences in different regions of the P. falciparum antigen Pf155/RESA. J Immunol (1989) 1.21
HA14-1 selectively induces apoptosis in Bcl-2-overexpressing leukemia/lymphoma cells, and enhances cytarabine-induced cell death. Leukemia (2003) 1.18
Risk of hepatitis C virus transmission through drug preparation equipment: a systematic and methodological review. J Viral Hepat (2008) 1.18
Severe malaria in Gambian children is not due to lack of previous exposure to malaria. Clin Exp Immunol (1992) 1.17
Cell-specific immuno-probes for the brain of normal and mutant Drosophila melanogaster. I. Wildtype visual system. Cell Tissue Res (1988) 1.16
Aflatoxin exposure, malaria and hepatitis B infection in rural Gambian children. Trans R Soc Trop Med Hyg (1992) 1.15
Paracheck Pf compared with microscopy for diagnosis of Plasmodium falciparum malaria among children in Tanga City, north-eastern Tanzania. Tanzan J Health Res (2008) 1.14
Indoor residual spraying with alphacypermethrin controls malaria in Pakistan: a community-randomized trial. Trop Med Int Health (2000) 1.12
Spatial and temporal risk factors for the early detection of Trypanosoma brucei rhodesiense sleeping sickness patients in Tororo and Busia districts, Uganda. Trans R Soc Trop Med Hyg (2004) 1.12
Performance-based measurements among elderly drivers and nondrivers. J Am Geriatr Soc (1988) 1.12
Primary malignant lymphoma of the central nervous system. Results of treatment of 11 cases and review of the literature. J Neurosurg (1986) 1.12
Differential effect of cigarette smoking on recirculating T lymphocyte subsets in pregnant women. J Immunol (1986) 1.12
Distribution and spread of pyrethroid and DDT resistance among the Anopheles gambiae complex in Tanzania. Med Vet Entomol (2013) 1.10
Testicular lymphoma: late relapses and poor outcome despite doxorubicin-based therapy. J Clin Oncol (1995) 1.10
Myostatin regulates cell survival during C2C12 myogenesis. Biochem Biophys Res Commun (2001) 1.10
A double-blind placebo-controlled randomized phase III trial of 5-fluorouracil and leucovorin, plus or minus trimetrexate, in previously untreated patients with advanced colorectal cancer. Ann Oncol (2002) 1.10
Identification of a lobe in the adult human pancreas rich in pancreatic polypeptide. Diabetologia (1979) 1.10
Prevalence of hospital-acquired infections in a tertiary referral hospital in northern Tanzania. Ann Trop Med Parasitol (2003) 1.08
An association between snowfall and ED presentation of cardiac arrest. Am J Emerg Med (1996) 1.08
The tryptic peptides of rabbit muscle triose phosphate isomerase. Biochem J (1974) 1.08
The North Staffordshire Maternity Hospital prospective study of pregnancy-associated depression. J Psychosom Obstet Gynaecol (2000) 1.08
HLA-DR and -DQ gene polymorphism in West Africans is twice as extensive as in north European Caucasians: evolutionary implications. Proc Natl Acad Sci U S A (1991) 1.07